CG Oncology Stock Signals Bullish Momentum Ahead

1. CGON enters Phase 2, indicating potential bullish momentum. 2. The Buddhi period follows consolidation, increasing breakout likelihood. 3. CGON has rallied 24% since initiating the Buddhi phase. 4. Investors should note large funds taking positions in CGON. 5. Bullish projections extend through April 2026 due to established patterns.